Salud de la Madre y el Niño

Elevated Lipoprotein(a) prevalence and association with family history of premature cardiovascular disease in general population with moderate cardiovascular risk and increased LDL cholesterol

P. E. Gulayin,A. Lozada,L. Schreier,L. Gutierrez,G. López,R. Poggio,N. Mores,J. Ponzo,M. Calandrelli,F. Lanas and V. Irazola. Elevated Lipoprotein(a) prevalence and association with family history of premature cardiovascular disease in general population with moderate cardiovascular risk and increased LDL cholesterol. Int J Cardiol Heart Vasc. 2022;42:10.1016/j.ijcha.2022.101100.

Elevated Lipoprotein(a) prevalence and association with family history of premature cardiovascular disease in general population with moderate cardiovascular risk and increased LDL cholesterol Ver más »

Efficacy and safety of triptorelin 6-month formulation in patients with central precocious puberty

K. Klein,J. Yang,J. Aisenberg,N. Wright,P. Kaplowitz,N. Lahlou,J. Linares,E. Lundström,D. Purcea and F. Cassorla. Efficacy and safety of triptorelin 6-month formulation in patients with central precocious puberty. J Pediatr Endocrinol Metab. 2016;29(11):10.1515/jpem-2015-0376.

Efficacy and safety of triptorelin 6-month formulation in patients with central precocious puberty Ver más »

Efficacy and safety of leuprolide acetate 3-month depot 11.25 milligrams or 30 milligrams for the treatment of central precocious puberty

P. A. Lee,K. Klein,N. Mauras,E. K. Neely,C. A. Bloch,L. Larsen,C. Mattia-Goldberg and K. Chwalisz. Efficacy and safety of leuprolide acetate 3-month depot 11.25 milligrams or 30 milligrams for the treatment of central precocious puberty. J Clin Endocrinol Metab. 2012;97(5):10.1210/jc.2011-2704.

Efficacy and safety of leuprolide acetate 3-month depot 11.25 milligrams or 30 milligrams for the treatment of central precocious puberty Ver más »

Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial

G. J. Hofmeyr,M. Singata-Madliki,T. A. Lawrie,E. Bergel and M. Temmerman. Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial. Reproductive Health. 2016;13:10.1186/s12978-016-0153-9.

Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial Ver más »

Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease

J. Yeboah,K. Klein,B. Brosnihan,D. Reboussin and D. M. Herrington. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease. Menopause. 2008;15(6):10.1097/gme.0b013e31816d8171.

Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease Ver más »

Effectiveness of uterine tamponade devices for refractory postpartum haemorrhage after vaginal birth: a systematic review

V. Pingray,M. Widmer,A. Ciapponi,G. J. Hofmeyr,C. Deneux,M. Gülmezoglu,K. Bloemenkamp,O. T. Oladapo,D. Comandé,A. Bardach,P. Vázquez,G. Cormick and F. Althabe. Effectiveness of uterine tamponade devices for refractory postpartum haemorrhage after vaginal birth: a systematic review. Bjog. 2021;128(11):10.1111/1471-0528.16819.

Effectiveness of uterine tamponade devices for refractory postpartum haemorrhage after vaginal birth: a systematic review Ver más »

Effect of dexamethasone on newborn survival at different administration-to-birth intervals: A secondary analysis of the WHO ACTION (Antenatal CorticosTeroids for Improving Outcomes in Preterm Newborn)-I trial

O. T. Oladapo,J. P. Vogel,G. Piaggio,M. H. Nguyen,F. Althabe,R. Bahl,S. P. Rao,A. D. Costa,S. Gupta,A. H. Baqui,M. Shahidullah,S. B. Chowdhury,S. S. Goudar,S. M. Dhaded,Z. P. Qureshi,F. Were,J. Kinuthia,A. I. Ayede,O. A. Adesina,O. Kuti,E. A. Adejuyigbe,S. Ariff,S. B. Soofi,L. Sheikh,J. Carvalho,V. A. Nilsson and L. Abreu. Effect of dexamethasone on newborn survival at different administration-to-birth intervals:

Effect of dexamethasone on newborn survival at different administration-to-birth intervals: A secondary analysis of the WHO ACTION (Antenatal CorticosTeroids for Improving Outcomes in Preterm Newborn)-I trial Ver más »

Effect of heat stable carbetocin vs oxytocin for preventing postpartum haemorrhage on post delivery hemoglobin-a randomized controlled trial

S. S. Vernekar,S. S. Goudar,M. Metgud,Y. V. Pujar,M. S. Somannavar,G. Piaggio,J. Carvalho,A. Revankar,F. Althabe,M. Widmer,A. M. Gulmezoglu and S. S. Goudar. Effect of heat stable carbetocin vs oxytocin for preventing postpartum haemorrhage on post delivery hemoglobin-a randomized controlled trial. J Matern Fetal Neonatal Med. 2022;35(25):10.1080/14767058.2021.2001799.

Effect of heat stable carbetocin vs oxytocin for preventing postpartum haemorrhage on post delivery hemoglobin-a randomized controlled trial Ver más »

Effect of a Community Health Worker-Led Multicomponent Intervention on Blood Pressure Control in Low-Income Patients in Argentina: A Randomized Clinical Trial

J. He,V. Irazola,K. T. Mills,R. Poggio,A. Beratarrechea,J. Dolan,C. S. Chen,L. Gibbons,M. Krousel-Wood,L. A. Bazzano,A. Nejamis,P. Gulayin,M. Santero,F. Augustovski,J. Chen and A. Rubinstein. Effect of a Community Health Worker-Led Multicomponent Intervention on Blood Pressure Control in Low-Income Patients in Argentina: A Randomized Clinical Trial. Jama. 2017;318(11):10.1001/jama.2017.11358.

Effect of a Community Health Worker-Led Multicomponent Intervention on Blood Pressure Control in Low-Income Patients in Argentina: A Randomized Clinical Trial Ver más »

Early evaluation of the ‘STOP SEPSIS!’ WHO Global Maternal Sepsis Awareness Campaign implemented for healthcare providers in 46 low, middle and high-income countries

V. Brizuela,M. Bonet,C. L. Trigo Romero,E. Abalos,A. Baguiya,B. Fawole,M. Knight,P. Lumbiganon,M. Minkauskienė,A. Nabhan,N. Bique Osman,Z. P. Qureshi and J. P. Souza. Early evaluation of the ‘STOP SEPSIS!’ WHO Global Maternal Sepsis Awareness Campaign implemented for healthcare providers in 46 low, middle and high-income countries. BMJ Open. 2020;10(5):10.1136/bmjopen-2019-036338.

Early evaluation of the ‘STOP SEPSIS!’ WHO Global Maternal Sepsis Awareness Campaign implemented for healthcare providers in 46 low, middle and high-income countries Ver más »